Zolmitriptan 2.5 mg PRN for Migraines
Zolmitriptan 2.5 mg taken as needed (PRN) is an effective and appropriate second-line treatment option for acute migraine attacks that have not responded to first-line NSAIDs. 1
Treatment Algorithm for Migraine
First-Line Therapy
- NSAIDs are recommended as first-line therapy for most migraine sufferers 2, 1
- Options include ibuprofen (400-800 mg), naproxen sodium (275-550 mg), aspirin (650-1000 mg)
- The combination of acetaminophen plus aspirin plus caffeine is also effective 2
Second-Line Therapy (When NSAIDs Fail)
- Triptans, including zolmitriptan 2.5 mg, are recommended when migraines do not respond to NSAIDs 2, 1
- Zolmitriptan 2.5 mg has demonstrated:
Dosing and Administration
- Zolmitriptan 2.5 mg can be taken orally every two hours as needed
- Maximum dosage: 10 mg per 24 hours 2
- A second dose may be effective for persistent or recurrent headache 7
- To prevent medication-overuse headache, limit use to no more than twice per week 2
Contraindications and Precautions
- Avoid in patients with:
Common Side Effects
- Most adverse events are mild to moderate and transient 3, 6, 5
- Common side effects include:
- Asthenia (weakness)
- Dry mouth
- Nausea
- Dizziness
- Somnolence
- Paresthesia
- Warm sensation
- Chest tightness or pain 3
Special Considerations
- For migraines with significant nausea/vomiting, consider non-oral routes of administration 2, 1
- Zolmitriptan is available in an orally-disintegrating tablet form that can be taken without water, which may be advantageous when nausea is present 6
- Consider adding an antiemetic like metoclopramide if nausea is a significant component 2, 1
When to Consider Prevention
- If using acute medications (including zolmitriptan) more than twice per week 2, 1
- If experiencing two or more disabling attacks per month 2
- If acute treatments are contraindicated or ineffective 2
Clinical Pearls
- Zolmitriptan 2.5 mg has similar efficacy to sumatriptan 50 mg for headache relief at 2 hours 5
- The efficacy of zolmitriptan is maintained with repeated use over time, with no evidence of tachyphylaxis 3, 6
- Taking zolmitriptan early in the migraine attack may improve efficacy 6
- Headache recurrence with zolmitriptan 2.5 mg occurs in approximately 22% of patients 4
In conclusion, zolmitriptan 2.5 mg PRN is an effective second-line treatment for acute migraine attacks with a favorable efficacy and safety profile when used appropriately.